Cao et al. believed that the dysregulation of IGF2BP2 was related to insulin resistance, diabetes and carcinogenesis and may potentially become a powerful biomarker and candidate target for related diseases [24]. This evidence concerns the gene IGF2BP2 and diabetes mellitus.